Requires all peace officers to carry epinephrine autoinjectors in their vehicles or on their person police departments to budget sufficient funds to purchase the epinephrine and autoinjectors and for training of every peace officer.
Requires prescription drug manufacturers to file a detailed, updated list of each pharmaceutical sales representative engaged by the manufacturer and to pay an annual fee for each name listed with the department of business regulation.
Requires health plans that provide prescription benefits to cover at least one type of glucagon auto-injector, nasal spray, or formulation that does not require reconstitution to treat hypoglycemia. No copayment or deductible would be required.
Caps the total amount that a covered person is required to pay for a covered prescription inhaler, prescription device, or prescription equipment to twenty-five dollars ($25.00) per thirty (30) day supply.
Expands the DCYF powers by overseeing and administer comprehensive behavioral health services for children with serious emotional disturbances and children with developmental or functional disabilities.
Maddy summaryHB 5620 regulates prescription drug price increases in Rhode Island by imposing penalties on manufacturers who raise prices without supporting medical evidence. It targets drugs identified as having "unsupported price increases" through the Institute for Clinical and Economic Review (ICER) annual report. Manufacturers with over $250,000 in annual sales within the state face a penalty equal to 80% of the revenue difference between actual sales and what would have been earned at the previous year’s wholesale cost (adjusted for inflation). This law directly affects pharmaceutical companies selling prescription drugs in Rhode Island and aims to curb unjustified price hikes.
Requires the secretary of the executive office of health and human services to monitor and mandate changes to the price-setting practices of pharmacy benefit managers to prohibit the spread pricing payment model.
Requires DCYF to implement recommendations made by the child advocate and child fatality review panel within 6 months and provide a report of the measures taken to address the recommendations.
Caps amount payable for 30 day supply of equipment/supplies for insulin administration/glucose monitoring at $25 or equipment designed to last more than 30 days with no deductible commencing January 1, 2026.
Maddy summaryRhode Island's House of Representatives has passed HR 6023, a symbolic resolution proclaiming March 2025 as "Women's History Month" within the state. This resolution does not create new laws or affect any specific groups; it is a formal recognition of women's historical contributions. The resolution directs the Secretary of State to send certified copies to President Trump, Governor McKee, and Rhode Island's Congressional delegation. It aligns with the National Women's History Alliance's 2025 theme, "Moving Forward Together! Women Educating & Inspiring Generations," but does not implement any policy changes.
